Summary & Overview
CPT 38794: Thoracic Duct Cannulation with Injection
CPT code 38794 covers percutaneous cannulation of the thoracic duct with administration of medication and removal of the cannula for diagnostic or therapeutic purposes. This specialized interventional procedure is significant nationally because it addresses lymphatic system anomalies and enables targeted delivery of agents for diagnosis or treatment, often managed by interventional radiologists or surgeons in hospital-based settings.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, comparisons of payer coverage approaches, common modifiers seen on claims, and operational benchmarks where available. The publication also outlines coding implications for service lines that commonly bill this procedure and highlights items for billing compliance and documentation clarity.
This summary is intended for national audiences seeking a clear understanding of the clinical service represented by CPT code 38794, its relevance to hospital and interventional service lines, and the payer landscape that affects authorization, coverage, and claims processing.
Billing Code Overview
CPT code 38794 describes the insertion of a cannula into the thoracic duct, administration of medication, and removal of the cannula. This procedure is performed to address anomalies of the thoracic duct and to inject substances for therapeutic or diagnostic purposes.
-
Service type: Percutaneous thoracic duct cannulation with injection (diagnostic or therapeutic)
-
Typical site of service: Hospital inpatient or outpatient setting, or specialized interventional radiology suite
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with recurrent chylous pleural effusions secondary to thoracic duct injury presents for image-guided thoracic duct cannulation and intraductal therapeutic injection. The patient has persistent dyspnea and chest tube drainage of milky fluid despite conservative measures (dietary modification, octreotide). After multidisciplinary review, interventional radiology schedules transcervical or transabdominal catheterization of the thoracic duct under fluoroscopic and ultrasound guidance for direct cannulation, contrast lymphangiography, and instillation of sclerosing agent or embolic material. The procedure workflow includes pre-procedure consent and evaluation, sterile preparation and ultrasound localization of lymphatic channels, cannulation of a lymphatic vessel and advancement into the thoracic duct, injection of diagnostic or therapeutic agents, confirmation of intraductal placement with contrast, and removal of the cannula with hemostasis. Post-procedure monitoring in the recovery area includes vital signs, chest radiograph if indicated, and brief observation for complications such as bleeding or pulmonary embolism. Typical site of service is an interventional radiology suite or hybrid operating room; service type is an image-guided intraductal therapeutic/diagnostic intervention.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When only the physician component is billed separate from the facility for image interpretation or physician-performed portion |